Novavax Inc Stock Prediction
AI-powered sentiment analysis and prediction trends for NVAX, updated each market day.
NVAX AI Sentiment
AI predicts Novavax Inc stock is likely to increase over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Novavax Inc
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.
Sector
Exchange
Market Cap
$1,391,472,970
Cap Tier
Employees
749
Headquarters
GAITHERSBURG, MD
Listed Since
Dec. 5, 1995
Website
NVAX Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
NVAX Volatility
Novavax Inc has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
